| | 1 | = LhARA end station R&D and vertical beam line development meeting : 21Sep21; xx:00 BST = |
| | 2 | |
| | 3 | == Notes == |
| | 4 | |
| | 5 | __2 year objectives:__ |
| | 6 | 1. Consultation with ‘users’. TP ran an earlier consultation – results from this should be fed into this consultation. We note that there will be differing requirements for different users, for example. |
| | 7 | a. Jason P set up could be relatively simple but could need additional infrastructure for hypoxia among other requirements |
| | 8 | b. RFI – objectives here are much more complex and require significant infrastructure investment. |
| | 9 | 2. Systems engineering – basic reality check – layout - see previous Neil Bliss input to WP6 |
| | 10 | 3. ‘Small’ investment in BU beamtime. Can we provide money for access costs for Birmingham and use this to attract other diagnostics groups. ~£1k/day – 20-25 days over 2 years? Set up days can be zero cost to user if appropriately scheduled. |
| | 11 | |
| | 12 | __5 year objectives:__ |
| | 13 | |
| | 14 | Instrumentation of a ‘low energy’ system fit for use. Requires beam monitoring on beamline and immediately before test station. |
| | 15 | Diagnostics should include: |
| | 16 | 1. Current pick ups |
| | 17 | 2. CarstenW gas system |
| | 18 | a. Post Doc plus PhD? |
| | 19 | b. Needs expt |
| | 20 | 3. Sci Wire – JM RAL |
| | 21 | 4. TPrice larger 2D system |
| | 22 | 5. Outcomes from yr1-2 task3 |
| | 23 | |
| | 24 | __Additional notes:__ |
| | 25 | |
| | 26 | • TP notes Ionisation chamber will not work – NPL input confirms this. |
| | 27 | • TP discuss with Stuart Green ‘other groups with money’ potential to collate numerous smaller money pots to provide sufficient funds for end station work. |
| | 28 | • JP if it were possible to get Birmingham vertical beam line up and running relatively quickly, we could use Birmingham as a test bed for LhARA, this would allow tests at a mock-up an end station. In terms of diagnostics testing the vertical beam line is not required. |
| | 29 | |
| | 30 | ---- |